Compare

Aegon/$AEG

1D1W1M3M6MYTD1Y5YMAX

About Aegon

Aegon is a life insurance and long-term savings business listed in the Netherlands. It was listed on the Amsterdam Stock Exchange in the 1980s and now has mature operations in the United States, the United Kingdom, and four growth markets of Brazil, China, Portugal, and Spain. In recent years, Aegon has been moving through an extensive transformation program during which management has sought to divest noncore operations and improve the risk profile of the business. Financial assets are the parts of the company that are now being run off. Aegon is looking to cycle out of capital-consumptive and volatile earnings products and recycle capital into capital-light and more predictable strategic businesses.
Ticker
$AEG
Sector
Finance
Primary listing
NYSE
Employees
12,100

Aegon Metrics

BasicAdvanced
$12B
11.87
$0.69
0.62
$0.41
5.04%

What the Analysts think about Aegon

Analyst ratings (Buy, Hold, Sell) for Aegon stock.
Analyst projections of the future price of Aegon stock.

Bulls say / Bears say

First-half 2026 operating result rose 9% to €804 million and operating capital generation increased 27% to €416 million. That points to stronger earnings and capital generation, although favourable markets also helped. (Aegon)
Transamerica’s new individual life sales rose 54% in the first half, and its World Financial Group network passed 100,000 agents. This gives Aegon a growing distribution base in its core US market. (Aegon)
Aegon increased its second-half 2026 buyback plan to €350 million and raised its interim dividend by 11% to €0.21 per share. The higher payout offers a direct return to shareholders while the group reshapes its business. (Aegon)
The group solvency ratio fell 15 percentage points from year-end 2025 to 169% at June 2026. Market losses and capital returns contributed to the decline, leaving less headroom than at the start of the year. (Aegon)
Aegon booked €294 million of charges in the Americas after updating assumptions on policyholder behaviour and mortality. Further adverse experience in these legacy policies could make earnings and capital less predictable. (Aegon)
The move to US domicile and US GAAP adds transition costs and uncertainty over how investors will assess the business. JPMorgan downgraded Aegon to Neutral in October, citing uncertainty around the transition and less scope for earnings or capital-return surprises. (Aegon, Markets Insider)
Data summarised monthly by Lightyear AI. Last updated on 2 Nov 2026.

Aegon Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Aegon Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.